Preclinical Molecular Imaging for Precision Medicine in Breast Cancer Mouse Models.
Animals
Antineoplastic Agents
/ pharmacokinetics
Breast Neoplasms
/ chemistry
Cell Line, Tumor
Diagnostic Imaging
/ methods
Drug Resistance, Neoplasm
Estrogens
Female
Forecasting
Humans
Mice
Mice, Knockout
Molecular Imaging
/ methods
Neoplasm Proteins
/ analysis
Neoplasm Transplantation
Neoplasms, Hormone-Dependent
/ diagnostic imaging
Precision Medicine
/ methods
Progesterone
Radiopharmaceuticals
Receptor, ErbB-2
/ analysis
Recombinant Fusion Proteins
STAT1 Transcription Factor
/ deficiency
Sensitivity and Specificity
Trastuzumab
/ pharmacokinetics
Xenograft Model Antitumor Assays
/ methods
Journal
Contrast media & molecular imaging
ISSN: 1555-4317
Titre abrégé: Contrast Media Mol Imaging
Pays: England
ID NLM: 101286760
Informations de publication
Date de publication:
2019
2019
Historique:
received:
01
02
2019
revised:
28
04
2019
accepted:
25
07
2019
entrez:
11
10
2019
pubmed:
11
10
2019
medline:
22
7
2020
Statut:
epublish
Résumé
Precision and personalized medicine is gaining importance in modern clinical medicine, as it aims to improve diagnostic precision and to reduce consequent therapeutic failures. In this regard, prior to use in human trials, animal models can help evaluate novel imaging approaches and therapeutic strategies and can help discover new biomarkers. Breast cancer is the most common malignancy in women worldwide, accounting for 25% of cases of all cancers and is responsible for approximately 500,000 deaths per year. Thus, it is important to identify accurate biomarkers for precise stratification of affected patients and for early detection of responsiveness to the selected therapeutic protocol. This review aims to summarize the latest advancements in preclinical molecular imaging in breast cancer mouse models. Positron emission tomography (PET) imaging remains one of the most common preclinical techniques used to evaluate biomarker expression
Identifiants
pubmed: 31598114
doi: 10.1155/2019/8946729
pmc: PMC6778915
doi:
Substances chimiques
Antineoplastic Agents
0
Estrogens
0
Neoplasm Proteins
0
Radiopharmaceuticals
0
Recombinant Fusion Proteins
0
STAT1 Transcription Factor
0
Stat1 protein, mouse
0
affibody (ZHER2-342)2
0
Progesterone
4G7DS2Q64Y
ERBB2 protein, human
EC 2.7.10.1
Receptor, ErbB-2
EC 2.7.10.1
Trastuzumab
P188ANX8CK
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
8946729Informations de copyright
Copyright © 2019 M. F. Fiordelisi et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflicts of interest.
Références
Int J Mol Sci. 2017 Dec 16;18(12):null
pubmed: 29258188
Cancer Imaging. 2011 Jun 28;11:76-90
pubmed: 21771711
Genes Dev. 2003 Mar 1;17(5):545-80
pubmed: 12629038
Electromagn Waves (Camb). 2014;147:1-22
pubmed: 25642127
Korean J Radiol. 2013 Jul-Aug;14(4):589-96
pubmed: 23901316
Theranostics. 2017 Aug 22;7(14):3595-3607
pubmed: 28912898
PLoS One. 2011;6(6):e20594
pubmed: 21731618
J Biophotonics. 2012 Nov;5(11-12):860-7
pubmed: 22887708
Rep Prog Phys. 2013 Sep;76(9):096601
pubmed: 24006360
Eur J Radiol. 2012 Mar;81(3):e217-22
pubmed: 21349667
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
PLoS One. 2018 May 23;13(5):e0197754
pubmed: 29791503
Nat Rev Cancer. 2014 Jul;14(7):481-93
pubmed: 24943811
Eur J Nucl Med Mol Imaging. 2008 May;35(5):1008-18
pubmed: 18157531
Int J Mol Sci. 2017 Apr 12;18(4):null
pubmed: 28417933
Radiology. 2008 Sep;248(3):925-35
pubmed: 18647846
Clin Cancer Res. 2009 Dec 1;15(23):7266-76
pubmed: 19934303
Clin Cancer Res. 2007 Jan 1;13(1):323-30
pubmed: 17200371
J Nucl Med. 2012 Apr;53(4):629-37
pubmed: 22410461
Adv Cancer Res. 2014;124:235-56
pubmed: 25287691
J Nucl Med. 2012 Jul;53(7):1119-26
pubmed: 22669982
Cancer Discov. 2014 Sep;4(9):998-1013
pubmed: 25185190
Chem Soc Rev. 2015 Jul 21;44(14):4792-834
pubmed: 25777768
Mol Cancer Ther. 2006 Nov;5(11):2624-33
pubmed: 17121909
Int J Nanomedicine. 2014 Mar 11;9:1323-37
pubmed: 24648731
Eur J Nucl Med Mol Imaging. 2004 May;31(5):720-4
pubmed: 14991243
Med Phys. 2005 Apr;32(4):1128-39
pubmed: 15895597
Biomaterials. 2009 May;30(15):2912-8
pubmed: 19251316
Clin Radiol. 2010 Jul;65(7):567-81
pubmed: 20541656
Eur J Radiol. 2012 Oct;81(10):2710-6
pubmed: 22093958
Eur J Radiol. 2015 Sep;84(9):1685-93
pubmed: 25851932
Magn Reson Imaging. 2018 Feb;46:10-20
pubmed: 29066294
J Orthop Res. 2008 Apr;26(4):522-30
pubmed: 17985393
J Exp Clin Cancer Res. 2008 Oct 17;27:52
pubmed: 18928537
BMC Cancer. 2011 Aug 19;11:361
pubmed: 21854572
Br J Radiol. 2016 Jul;89(1063):20150961
pubmed: 27187599
J Nucl Med. 2016 Feb;57 Suppl 1:60S-8S
pubmed: 26834104
Br J Cancer. 2001 May 18;84(10):1424-31
pubmed: 11355958
Mol Imaging Biol. 2006 Jan-Feb;8(1):36-42
pubmed: 16362149
Recent Results Cancer Res. 2013;187:257-310
pubmed: 23179885
Radiology. 2008 Feb;246(2):508-18
pubmed: 18180339
Eur Radiol. 2013 Feb;23(2):468-75
pubmed: 22878592
Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):153-9
pubmed: 23790511
Semin Ultrasound CT MR. 2018 Feb;39(1):45-59
pubmed: 29317039
Mol Diagn Ther. 2014 Apr;18(2):153-73
pubmed: 24146172
Breast Cancer Res. 2001;3(1):41-6
pubmed: 11250744
NeuroRx. 2005 Apr;2(2):167-96
pubmed: 15897944
Curr Pharm Des. 2001 Dec;7(18):1863-92
pubmed: 11772355
J Nucl Med. 2016 Feb;57(2):171-2
pubmed: 26405165
Clin Cancer Res. 2012 Feb 15;18(4):1073-81
pubmed: 22235098
Oncotarget. 2017 Oct 7;8(55):94969-94979
pubmed: 29212283
Radiology. 2011 Mar;258(3):804-11
pubmed: 21339349
Front Pharmacol. 2019 Mar 15;10:235
pubmed: 30930779
J Natl Compr Canc Netw. 2013 Jul;11(7):753-60; quiz 761
pubmed: 23847214
Radiol Med. 2009 Feb;114(1):152-67
pubmed: 19082783
Semin Nucl Med. 1999 Jan;29(1):49-56
pubmed: 9990683
Magn Reson Imaging Clin N Am. 2013 Aug;21(3):601-24
pubmed: 23928248
Cancer Res. 2013 Mar 15;73(6):1689-98
pubmed: 23328585
J Magn Reson Imaging. 2019 Jan;49(1):23-40
pubmed: 30311988
Transl Oncol. 2014 Dec;7(6):768-79
pubmed: 25500087
J Comput Assist Tomogr. 2001 Jul-Aug;25(4):515-9
pubmed: 11473179
Sci Rep. 2017 Jul 26;7(1):6584
pubmed: 28747642
J Ultrasound Med. 2008 Jun;27(6):855-66
pubmed: 18499845
Chin J Traumatol. 2016 Oct 1;19(5):249-250
pubmed: 27780501
Radiology. 2014 Aug;272(2):385-96
pubmed: 24738612
Insights Imaging. 2011 Dec;2(6):621-630
pubmed: 22347981
NMR Biomed. 2017 Nov;30(11):null
pubmed: 28915312
Pol J Radiol. 2018 May 18;83:e220-e228
pubmed: 30627239
Quant Imaging Med Surg. 2015 Jun;5(3):407-22
pubmed: 26029644
Clin Cancer Res. 2011 Dec 15;17(24):7664-72
pubmed: 22028493
J Natl Compr Canc Netw. 2017 Apr;15(4):433-451
pubmed: 28404755
Curr Protoc Pharmacol. 2013 Mar;Chapter 14:Unit14.23
pubmed: 23456611
Eur J Radiol. 2009 May;70(2):274-85
pubmed: 19268515
N Engl J Med. 2015 Jun 4;372(23):2229-34
pubmed: 26014593
Eur Radiol. 2003 Jan;13(1):195-208
pubmed: 12541130
ILAR J. 2001;42(3):233-47
pubmed: 11406722
J Clin Oncol. 2000 Oct 15;18(20):3495-502
pubmed: 11032590
Front Neurosci. 2018 Feb 26;12:102
pubmed: 29535599
Eur J Radiol. 2017 Sep;94:154-159
pubmed: 28712703
J Magn Reson Imaging. 1998 Sep-Oct;8(5):1126-34
pubmed: 9786152
Clin Orthop Relat Res. 1989 Jul;(244):7-16
pubmed: 2663291
Mol Imaging Biol. 2018 Oct;20(5):696-704
pubmed: 30030697
Front Oncol. 2016 Jun 23;6:150
pubmed: 27446798
Cancer Res. 2007 Feb 1;67(3):1138-44
pubmed: 17283148
J Nucl Med. 2012 Mar;53(3):345-8
pubmed: 22393225
Med Phys. 2014 Dec;41(12):124301
pubmed: 25471985
J Med Ultrasound. 2009;17(1):25-30
pubmed: 20445825
Contrast Media Mol Imaging. 2019 Apr 30;2019:5080267
pubmed: 31182936
Eur J Surg Oncol. 2006 Feb;32(1):39-43
pubmed: 16269226
Philos Trans R Soc Lond B Biol Sci. 1997 Jun 29;352(1354):717-26
pubmed: 9232860
Mol Imaging Biol. 2015 Feb;17(1):119-28
pubmed: 25034624
Rev Esp Med Nucl Imagen Mol. 2014 Jan-Feb;33(1):14-21
pubmed: 23809513
J Nucl Med. 2009 Jul;50(7):1131-9
pubmed: 19525458
Clin Cancer Res. 2009 Jul 15;15(14):4712-21
pubmed: 19584166
Biotechniques. 2001 May;30(5):1016-22, 1024-6
pubmed: 11355337
Oncotarget. 2016 Nov 29;7(48):79428-79441
pubmed: 27765906
Bioconjug Chem. 2004 Jan-Feb;15(1):79-86
pubmed: 14733586
Cancer Res. 2009 Apr 15;69(8):3364-73
pubmed: 19351829
Conf Proc IEEE Eng Med Biol Soc. 2009;2009:1953-5
pubmed: 19964020
Mol Cancer Ther. 2011 Aug;10(8):1311-6
pubmed: 21673092
NMR Biomed. 2019 Jan;32(1):e4026
pubmed: 30379384
J Clin Invest. 2011 Jul;121(7):2750-67
pubmed: 21633166
Clin Lab Med. 2016 Sep;36(3):447-59
pubmed: 27514461